STA
IDXX icon

Summit Trail Advisors’s Idexx Laboratories IDXX Stock Holding History

Summit Trail Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.51M Buy
4,777
+993
+26% +$557K 0.03% 458
2026
Q1 		$2.13M Buy
3,784
+494
+15% +$317K 0.03% 478
2025
Q4 		$2.23M Sell
3,290
-211
-6% -$144K 0.04% 349
2025
Q3 		$2.24M Buy
3,501
+786
+29% +$477K 0.03% 387
2025
Q2 		$1.46M Buy
2,715
+1,474
+119% +$705K 0.03% 350
2025
Q1 		$521K Buy
1,241
+431
+53% +$187K 0.02% 250
2024
Q4 		$335K Buy
810
+26
+3% +$11.4K 0.01% 273
2024
Q3 		$396K Buy
784
+81
+12% +$39.4K 0.01% 459
2024
Q2 		$343K Sell
703
-98
-12% -$49.2K 0.01% 447
2024
Q1 		$432K Buy
801
+300
+60% +$164K 0.01% 369
2023
Q4 		$278K Sell
501
-61
-11% -$28.6K 0.01% 417
2023
Q3 		$246K Buy
562
+68
+14% +$33.9K 0.01% 440
2023
Q2 		$248K Buy
+494
New +$237K 0.01% 417
2022
Q2 		– Sell
-760
Closed -$416K – 398
2022
Q1 		$416K Buy
+760
New +$400K 0.03% 199
2018
Q1 		– Sell
-86
Closed -$16K – 1012
2017
Q4 		$16K Buy
+86
New +$13.5K ﹤0.01% 1102

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Summit Trail Advisors's IDXX Position: Q2 2026 in Review

Summit Trail Advisors increased its Idexx Laboratories (IDXX) stake by 26% in Q2 2026, buying an estimated $557K and bringing the position to 4,777 shares worth $2.51M. The position accounts for 0.03% of the portfolio, ranked #458.

Summit Trail Advisors first reported a position in IDXX in Q4 2017 and has held it in 15 quarters since. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Summit Trail Advisors held 4,777 shares of Idexx Laboratories worth $2.51M as of Q2 2026.
  • Summit Trail Advisors bought 993 Idexx Laboratories shares in Q2 2026, an estimated $557K.
  • Idexx Laboratories made up 0.03% of Summit Trail Advisors's portfolio in Q2 2026, its #458 holding.
  • Summit Trail Advisors first reported a position in Idexx Laboratories in Q4 2017 and has held it in 15 quarters since.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.